Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Ambrx Biopharma Inc ADR (AMAM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2023	03-2023	12-2022	06-2022	03-2022
Assets
Current Assets
Cash & Cash Equivalents	228,930	150,249	56,441	66,473	N/A
Marketable Securities	6,824	7,940	28,873	45,251	N/A
Receivables	81	62	376	1,466	N/A
TOTAL	$241,413	$162,942	$90,583	$121,006	$N/A

Non-Current Assets
PPE Net	3,195	2,889	3,044	3,146	N/A
Investments And Advances	0	8,798	16,793	18,827	0
Intangibles	24,935	25,093	25,250	25,565	0
Other Non-Current Assets	10,401	10,891	11,307	12,326	0
TOTAL	$38,531	$47,671	$56,394	$59,864	$N/A

Total Assets	$279,944	$210,613	$146,977	$180,870	$N/A

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	6,362	7,107	3,205	5,696	0
Accrued Expenses	9,556	6,782	11,314	15,585	N/A
TOTAL	$18,179	$16,089	$16,660	$25,738	$N/A

Non-Current Liabilities
Deferred Revenues	407	407	407	3,137	N/A
Other Non-Current Liabilities	9,163	9,710	10,245	11,251	0
TOTAL	$11,385	$11,932	$12,467	$13,240	$N/A

Total Liabilities	$29,564	$28,021	$29,127	$38,978	$N/A

Shareholders' Equity
Shares Outstanding, K	62,010	55,229	N/A	N/A	N/A
Common Shares	43	39	27	27	N/A
Retained earnings	-324,756	-306,930	-291,628	-265,121	N/A
Other shareholders' equity	-953	-976	-1,302	-1,007	0
TOTAL	$250,380	$182,592	$117,850	$141,892	$N/A

Total Liabilities And Equity	$279,944	$210,613	$146,977	$180,870	$0